We showed that no significant differences in serum IL-37 protein levels between the patients who had malar rash, serositis, arthritis, fever, neurological disorder, anemia, leucopenia and thrombocytopenia and the patients who absented the above-mentioned clinical manifestations (data not shown). This evidence concerns the gene IL37 and Thrombocytopenia.